SAN DIEGO, Sept. 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented a study that assessed the effects of 18 months of treatment with FORTEO ® (teriparatide [rDNA origin] ...

INDIANAPOLIS Eli Lilly has begun marketing a device for injecting its drug Forteo, the company announced Wednesday. Lilly said the Forteo Delivery Device was designed to make injection of the drug ...